New methodological approaches for assessing thrombus formation in cardiovascular disease

被引：3

作者：

Hosokawa, Kazuya ^{[1
]}

Ohnishi-Wada, Tomoko ^{[1
]}

Nagasato, Tomoka ^{[1
,2
]}

Sameshima-Kaneko, Hisayo ^{[1
]}

Oyamada, Chiaki ^{[1
]}

Dahlen, Jeffrey ^{[3
]}

机构：

[1] Fujimori Kogyo Co Ltd, Res Inst, Yokohama, Kanagawa, Japan

[2] Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima, Japan

[3] Hikari Dx, San Diego, CA USA

来源：

KARDIOLOGIA POLSKA | 2020年 / 78卷 / 7-8期

关键词：

anticoagulant therapy; antiplatelet therapy; AR chip; PL chip; Total Thrombus-Formation Analysis System; PLATELET-FUNCTION ANALYZER; ACUTE CORONARY SYNDROMES; FLOW-CHAMBER SYSTEM; WARFARIN; THROMBOGENICITY; RIVAROXABAN; CLOPIDOGREL; ASPIRIN; DABIGATRAN; APIXABAN;

D O I：

10.33963/KP.15493

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiplatelet therapy is the mainstay preventive strategy for cardiovascular diseases, and dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor is the standard treatment for patients who underwent percutaneous coronary intervention. The Total Thrombus-Formation Analysis System (T-TAS) is a microchip flow-chamber system developed to evaluate overall thrombus formation under flow conditions, which is reportedly able to assess single and combined antithrombotic therapy. Here, we focus on this new system, T-TAS, and review its characteristics together with those of the conventional systems available for evaluation of antithrombotic therapies for cardiovascular diseases.

引用

页码：667 / 673

页数：7

共 42 条

[1] Oral Apixaban for the Treatment of Acute Venous Thromboembolism [J].

Agnelli, Giancarlo ;

Buller, Harry R. ;

Cohen, Alexander ;

Curto, Madelyn ;

Gallus, Alexander S. ;

Johnson, Margot ;

Masiukiewicz, Urszula ;

Pak, Raphael ;

Thompson, John ;

Raskob, Gary E. ;

Weitz, Jeffrey I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :799-808

[2] Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'real-world' experience [J].

Ardillon, L. ;

Ternisien, C. ;

Fouassier, M. ;

Sigaud, M. ;

Lefrancois, A. ;

Pacault, M. ;

Ribeyrol, O. ;

Fressinaud, E. ;

Boisseau, P. ;

Trossaert, M. .

HAEMOPHILIA, 2015, 21 (05) :646-652

[3] Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy [J].

Arima, Y. ;

Kaikita, K. ;

Ishii, M. ;

Ito, M. ;

Sueta, D. ;

Oimatsu, Y. ;

Sakamoto, K. ;

Tsujita, K. ;

Kojima, S. ;

Nakagawa, K. ;

Hokimoto, S. ;

Ogawa, H. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (04) :850-859

[4] Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [J].

Bauersachs, Rupert ;

Berkowitz, Scott D. ;

Brenner, Benjamin ;

Buller, Harry R. ;

Decousus, Herve ;

Gallus, Alex S. ;

Lensing, Anthonie W. ;

Misselwitz, Frank ;

Prins, Martin H. ;

Raskob, Gary E. ;

Segers, Annelise ;

Verhamme, Peter ;

Wells, Phil ;

Agnelli, Giancarlo ;

Bounameaux, Henri ;

Cohen, Alexander ;

Davidson, Bruce L. ;

Piovella, Franco ;

Schellong, Sebastian .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2499-2510

[5]

Benetou DR, 2020, AM J CARDIOVASC DRUG

[6] Global Hemostasis Testing Thromboelastography: Old Technology, New Applications [J].

Chen, Alice ;

Teruya, Jun .

CLINICS IN LABORATORY MEDICINE, 2009, 29 (02) :391-+

[7] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[8] A novel modification of the thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation [J].

Craft, RM ;

Chavez, JJ ;

Bresse, SJ ;

Wortham, DC ;

Cohen, E ;

Carroll, RC .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2004, 143 (05) :301-309

[9] Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease [J].

Eikelboom, J. W. ;

Connolly, S. J. ;

Bosch, J. ;

Dagenais, G. R. ;

Hart, R. G. ;

Shestakovska, O. ;

Diaz, R. ;

Alings, M. ;

Lonn, E. M. ;

Anand, S. S. ;

Widimsky, P. ;

Hori, M. ;

Avezum, A. ;

Piegas, L. S. ;

Branch, K. R. H. ;

Probstfield, J. ;

Bhatt, D. L. ;

Zhu, J. ;

Liang, Y. ;

Maggioni, A. P. ;

Lopez-Jaramillo, P. ;

O'Donnell, M. ;

Kakkar, A. K. ;

Fox, K. A. A. ;

Parkhomenko, A. N. ;

Ertl, G. ;

Stoerk, S. ;

Keltai, M. ;

Ryden, L. ;

Pogosova, N. ;

Dans, A. L. ;

Lanas, F. ;

Commerford, P. J. ;

Torp-Pedersen, C. ;

Guzik, T. J. ;

Verhamme, P. B. ;

Vinereanu, D. ;

Kim, J. -H. ;

Tonkin, A. M. ;

Lewis, B. S. ;

Felix, C. ;

Yusoff, K. ;

Steg, P. G. ;

Metsarinne, K. P. ;

Bruns, N. Cook ;

Misselwitz, F. ;

Chen, E. ;

Leong, D. ;

Yusuf, S. ;

Aboyans, V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1319-1330

[10] External Quality Assessment/Proficiency Testing and Internal Quality Control for the PFA-100 and PFA-200: An Update [J].

Favaloro, Emmanuel J. ;

Bonar, Roslyn .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (02) :239-253

← 1 2 3 4 5 →